Mereo BioPharma Group plc ( MREO) - Key Metrics
MREO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.04 | -$0.04 | -$0.04 |
| 2026Q1 | $0 | -$0.04 | -$0.03 | -$0.03 |
| 2025Q4 | $0 | -$0.05 | -$0.05 | -$0.05 |
| 2025Q3 | $0 | -$0.04 | -$0.05 | -$0.05 |
| 2025Q2 | $0 | -$0.09 | -$0.05 | -$0.05 |
MREO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.59 |
| 2026Q1 | 0% | -1.96 |
| 2025Q4 | 0% | -2.26 |
| 2025Q3 | 0% | -11.70 |
| 2025Q2 | 0% | -7.32 |
MREO
Price: $0.32
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 278100
Market Capitalization: 48.3 million